Debut Plus

₹1,592

▲ +43.81 +2.83%

17 Jul 2026

BSE Listed · Pharmaceuticals

Novartis India Ltd. (500672)

Volume: 3,740Avg Vol 1W: 7,631Avg Vol 1M: 3,18952W Range:₹750₹1,722.2
BSE www.novartis.in
Key Ratios
Checked just now
Market Cap₹3,931 Cr
Current Price₹1,592
Previous Close₹1,548.19
High / Low (52w)₹1,722.2 / ₹750
Volume3,740
Avg Vol (1W)7,631
Avg Vol (1M)3,189
Stock P/E42.18
Book Value₹331.23
Dividend Yield0%
ROE11.39%
ROA9.52%
Revenue (TTM)—
Revenue Growth—
Profit Margin26.3%
Total Debt—
Shares Outstanding2 Cr
Face Value₹5
EPS (TTM)₹37.74
P/B4.81
Debt / Equity0.01
50 DMA₹1,378.16
200 DMA₹996.24
Day change+2.83%
Price Chart
₹1,592▲ 50.89% · 1Y
₹1688₹75910.3L
2025-07-16
2026-07-16

20-day avg volume: 3K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹92 Cr₹87 Cr₹93 Cr₹84 Cr₹88 Cr₹90 Cr₹86 Cr₹91 Cr
EBITDA₹34 Cr₹28 Cr₹36 Cr₹34 Cr₹37 Cr₹33 Cr₹31 Cr₹30 Cr
Net Profit₹26 Cr₹20 Cr₹25 Cr₹29 Cr₹28 Cr₹24 Cr₹16 Cr₹25 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹736 Cr₹569 Cr₹474 Cr₹414 Cr₹433 Cr₹437 Cr₹397 Cr₹398 Cr
EBITDA₹163 Cr₹87 Cr₹35 Cr₹48 Cr₹51 Cr₹117 Cr₹124 Cr₹131 Cr
Net Profit₹78 Cr₹52 Cr₹10 Cr₹21 Cr₹-4 Cr₹103 Cr₹85 Cr₹101 Cr
EPS28.4320.974.088.46-1.5141.8634.540.87
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,111 Cr₹982 Cr₹1,078 Cr₹1,002 Cr₹958 Cr₹983 Cr₹925 Cr₹948 Cr
Total Liabilities₹377 Cr₹223 Cr₹357 Cr₹291 Cr₹266 Cr₹207 Cr₹180 Cr₹163 Cr
Equity₹734 Cr₹759 Cr₹721 Cr₹711 Cr₹692 Cr₹776 Cr₹745 Cr₹785 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024
Operating₹-34 Cr₹57 Cr₹42 Cr₹75 Cr
Investing₹95 Cr₹87 Cr₹-153 Cr₹33 Cr
Financing₹-37 Cr₹-36 Cr₹-30 Cr₹-121 Cr
Free Cash Flow₹-34 Cr₹57 Cr₹42 Cr₹75 Cr
Shareholding
Promoter 70.68% Institutions 0.71% Public 28.61%
Efficiency & Working Capital
ROCE15.9%
Interest Coverage170.4
Dividend Payout—
Debtor Days41 d
Inventory Days42 d
Payable Days53 d
Cash Conversion Cycle31 d
Working Capital Days83 d
Shareholding Details

As of 2026-03-31

Promoter70.7%
FII0.2%
DII0.5%
Institutions0.7%
Public28.6%
Promoter Pledge0%
No. of Shareholders38,116
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters70.7%70.7%70.7%70.7%70.7%70.7%70.7%70.7%70.7%70.7%70.7%70.7%
FIIs0.2%0.3%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.2%
DIIs0.8%0.5%0.5%0.5%0.5%0.5%0.5%0.5%0.5%0.5%0.6%0.5%
Public28.3%28.5%28.6%28.6%28.6%28.6%28.6%28.6%28.6%28.6%28.5%28.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders43,34343,99243,12841,23939,26539,59638,92639,13339,04039,35339,46838,116
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Novartis AgShareholding of Promoter and Promoter Group70.7%1.75 Cr
Atul LimitedPublic Shareholding1.5%3,74,627
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Novartis Ag00%2026-03-31
Atul Limited00%2026-03-31
Novartis Ag00%2025-12-31
Atul Limited00%2025-12-31
Novartis Ag00%2025-09-30
Foreign Institutional Investors00%2025-09-30
Atul Limited00%2025-09-30
Novartis Ag00%2025-06-30
Atul Limited00%2025-06-30
Novartis Ag00%2025-03-31
Atul Limited00%2025-03-31
Novartis Ag00%2024-12-31
Board of Directors
NameDesignationYear
C SnookChairman (Non-Executive)2025
Sandra MartryesIndependent Director2025
SANKER PARAMESWARANIndependent Director2025
Shilpa JoshiWhole Time Director & Chief Financial Officer2025
Chandni MaruCompany Sec. & Compli. Officer2025
Gira SardesaiIndependent Director2025
Falin MajmudarWhole Time Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹653 Cr80.8%
Generics₹39 Cr4.8%
OTC₹39 Cr4.8%
Animal Health₹77 Cr9.6%
Segments — Geography
RegionRevenueShare
India₹648 Cr98.8%
Other Countries₹8 Cr1.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹5321212
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-23Board Meetings—
dividend2025-07-23₹25 (500%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025910014144
2025100001
2025100001
Company Information
Incorporated1947
ChairmanC Snook
AuditorB S R & Co LLP
Investor Email[email protected]
🌐 www.novartis.in ↗

📍 The Inspire BKC Part 601 & 701, Bandra Kurla Complex Bandra(E), Mumbai, Maharashtra, 400051

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Tata Motors Passenger VehiclesGreat Eastern Shipping CompanyDeepak Fertilisers & PetrochemicalsGarware Hi-Tech Films LimitedGlaxoSmithKline PharmaceuticalsGujarat Narmada Valley Fert & ChemSanofiGujarat State Fertilizers & ChemicalsNOCILNestleTata Consumer ProductsAsian PaintsAll “50” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search